ArticleFrontiers in pharmacology2024

CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder.

Cataldo Martucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.